In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen

British Journal of Cancer

Volumn 108, Issue 3, 2013, Pages 570-578

  Kretschy, N ^a   Teichmann, M ^a   Kopf, S ^a   Atanasov, A G ^b   Saiko, P ^a   Vonach, C ^a   Viola, K ^a   Giessrigl, B ^a   Huttary, N ^a   Raab, I ^a   Krieger, S ^a   Jager W ^b   Szekeres, T ^a   Nijman, S M ^c   Mikulits, W ^d   Dirsch, V M ^b   Dolznig, H ^a   Grusch, M ^d   Krupitza, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ACETOHEXAMIDE; DODECYL SULFATE SODIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOXSUPRINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN LIGHT CHAIN 2; MYOSIN PHOSPHATASE; NIFEDIPINE; PAXILLIN; PHOSPHATASE; PROADIFEN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL MIGRATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; DRUG SCREENING; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; FATTY ACID SYNTHESIS; GENE REPRESSION; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; LYMPH VESSEL; METASTASIS INHIBITION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR EMBOLISM; TUMOR SPHEROID; WESTERN BLOTTING;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ACETOHEXAMIDE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL ADHESION; CELL MOVEMENT; CHEMOTAXIS; COCULTURE TECHNIQUES; DRUG SYNERGISM; ENDOTHELIUM, LYMPHATIC; ENZYME INHIBITORS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; ISOXSUPRINE; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; NF-KAPPA B; NIFEDIPINE; PROADIFEN; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; VASODILATOR AGENTS;

EID: 84875210635     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.580     Document Type: Article

References (48)

1. Belloli C, Carcano R, Arioli F, Beretta C (2000) Affinity of isoxsuprine for adrenoreceptors in equine digital artery and implications for vasodilatory action. Equine Vet J 32(2): 119-124.
2. Boeynaems JM, Demolle D, Van Coevorden A (1987) Stimulation of vascular prostacyclin by SKF 525-A (proadifen) and related compounds. Biochem Pharmacol 36(10): 1637-1643.
3. Chou TC, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27-55.
4. Chou TC, Talalay P (1981) Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. Eur J Biochem (FEBS) 115: 207-216.
5. Deakin NO, Turner CE (2008) Paxillin comes of age. J Cell Sci 121(15): 2435-2444.
6. Digman MA, Brown CM, Horwitz AM, Mantulin WW, Gratton E (2008) Paxillin dynamics measured during adhesion assembly and disasembly by correlation spectroscopy. Biophys J 94(7): 2819-2831.
7. Erkert RS, Macallister CG (2002) Isoxsuprine hydrochloride in the horse: a review. J Vet Pharmacol Ther 25(2): 81-87.
8. Feng J, Masaaki I, Ichikawa K, Isaka N, Nishikawa M, Hartshorne DJ, Nakano T (1999) Inhibitory phosphorylation site for rho-associated kinase on smooth muscle myosin phosphatase. J Cell Biol 274: 37385-37390.
9. Folmer F, Jaspars M, Solano G, Cristofanon S, Henry E, Tabudravu J, Black K, Green DH, Küpper FC, Aalbersberg W, Feussner K, Dicato M, Diederich M (2009) The inhibition of TNF-a induced NF-kB activation by marine natural products. Biochem Pharmacol 78: 592-606.
10. Funk CD (1996) The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochim Biophys Acta 1304(1): 65-84.
11. Giessrigl B, Yazici G, Teichmann M, Kopf S, Ghassemi S, Atanasov AG, Dirsch VM, Grusch M, Jäger W, Ö zmen A, Krupitza G (2012) Effects of scrophularia extracts on tumor cell proliferation, death and intravasation through lymphendothelial cell barriers. Int J Oncol 40(6): 2063-2074.
12. Giorgino FL, Egan CG (2010) Use of isoxsuprine hydrochloride as a tocolytic agent in the treatment of preterm labour: a systematic review of previous literature. Arzneimittelforschung 60(7): 415-420.
13. Grusch M, Polgar D, Gfatter S, Leuhuber K, Huettenbrenner S, Leisser C, Fuhrmann G, Kassie F, Steinkellner H, Smid K, Peters GJ, Jayaram H, Klepal T, Szekeres T, Knasmüller S, Krupitza G (2002) Maintenance of ATP favours apoptosis over necrosis triggered by benzamide riboside. Cell Death Differ 9: 169-178.
14. Honn KV, Tang DG, Grossi I, Duniec ZM, Timar J, Renaud C, Leithauser M, Blair I, Johnson CR, Diglio CA, Kimler VA, Taylor JD, Marnett LJ (1994) Tumour cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction. Cancer Res 54: 565-574.
15. Huang C, Rajfur Z, Borchers C, Schaller MD, Jacobson K (2003) JNK phosphorylates paxillin and regulates cell migration. Nature 424: 219-223.
16. Ikebe M, Hartshorne DJ (1985) Phosphorylation of smooth muscle myosin at two distinct sites by myosin light chain kinase. J Biol Chem 260(18): 10027-10031.
17. Imamura Y, Kojima Y, Otagiri M (1989) Influence of streptozocin-induced diabetes on reductive metabolism of acetohexamide in rat liver. J Pharm Pharmacol 41(3): 186-187.
18. Jiang JG, Ning YG, Chen C, Ma D, Liu ZJ, Yang S, Zhou J, Xiao X, Zhang XA, Edin ML, Card JW, Wang J, Zeldin DC, Wang DW (2007) Cytochrome p450 epoxygenase promotes human cancer metastasis. Cancer Res 67(14): 6665-6674.
19. Jianxin AY, Deakin NO, Turner CE (2009) Paxillin-kinase-linker tyrosine phosphorylation regulates directional cell migration. Mol Biol Cell 20(22): 4706-4719.
20. Kanmura Y, Itoh T, Suzuki H, Ito Y, Kuriyama H (1983) Effects of nifedipine on smooth muscle cells of the rabbit mesenteric artery. J Pharmacol Exp Ther 226(1): 238-248.
21. Kato K, Ishida M, Azuma Y, Nakanishi S (1971) Effect of isoxsuprine HCl on the mechanism of relaxation of the uterine muscle. Nihon Sanka Fujinka Gakkai Zasshi 23(9): 825-830.
22. Kerjaschki D, Bago-Horvath Z, Rudas M, Sexl V, Schneckenleithner C, Wolbank S, Bartel G, Krieger S, Kalt R, Hantusch B, Keller T, Nagy-Bojarszky K, Huttary N, Raab I, Lackner K, Krautgasser K, Schachner H, Kaserer K, Rezar S, Madlener S, Vonach C, Davidovits A, Nosaka H, Hämmerle M, Viola K, Dolznig H, Schreiber M, Nader A, Mikulits W, Gnant M, Hirakawa S, Detmar M, Alitalo K, Nijman S, Offner F, Maier TJ, Steinhilber D, Krupitza G (2011) Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J Clin Invest 121(5): 2000-2012.
23. Knoll LD, Benson Jr RC, Bilhartz DL, Minich PJ, Furlow WL (1996) A randomized crossover study using yohimbine and isoxsuprine versus pentoxifylline in the management of vasculogenic impotence. J Urol 155(1): 144-146.
24. Lu H, Murtagh J, Schwartz EL (2006) The microtubule binding drug laulimalide inhibits vascular endothelial growth factor-induced human endothelial cell migration and is synergistic when combined with docetaxel (taxotere). Mol Pharmacol 69(4): 1207-1215.
25. Lundy A, Lutfi N, Beckey C (2009) Review of nifedipine GITS in the treatment of high risk patients with coronary artery disease and hypertension. Vasc Health Risk Manag 5(1): 429-440.
26. Madlener S, Saiko P, Vonach C, Viola K, Huttary N, Stark N, Popescu R, Gridling M, Vo NT, Herbacek I, Davidovits A, Giessrigl B, Venkateswarlu S, Geleff S, Jäger W, Grusch M, Kerjaschki D, Mikulits W, Golakoti T, Fritzer-Szekeres M, Szekeres T, Krupitza G (2010) Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro. Br J Cancer 102(9): 1361-1370.
27. Metea MR, Newman EA (2006) Glial cells dilate and constrict blood vessels: a mechanism of neurovascular coupling. J Neurosci 26(11): 2862-2870.
28. Nakamura T (1984) Influences of oral hypoglycemic agents on the beta-cell of the rabbit pancreas. Nihon Ika Daigaku Zasshi 51(3): 332-338.
29. Orlowski RZ, Baldwin AS (2002) NF-kB as a therapeutic target in cancer. Trends Mol Med 8(8): 385-389.
30. Parsons SA, Sharma R, Roccamatisi DL, Zhang H, Petri B, Kubes P, Colarusso P, Patel KD (2012) Endothelial paxillin and focal adhesion kinase (FAK) play a critical role in neutrophil transmigration. Eur J Immunol 42(2): 436-446.
31. Paulitschke V, Schicher N, Szekeres T, Jäger W, Elbling L, Riemer AB, Scheiner O, Trimurtulu G, Venkateswarlu S, Mikula M, Swoboda A, Fiebiger E, Gerner C, Pehamberger H, Kunstfeld R (2010) 3,30,4,40,5,50-Hexahydroxystilbene impairs melanoma progression in a metastatic mouse model. J Invest Derm 130(6): 1668-1679.
32. Rice RL, Tang DG, Hddadi M, Honn KV, Taylor JD (1998) 12(S)-Hydroxyeicosatetraenoic acid increases microfilament content in B16a melanoma cells: a protein kinase-dependent process. Int J Cancer 77: 271-278.
33. Sakuta H, Yoneda I (1994) Inhibition by SKF 525A and quinacrine of endogenous glibenclamide-sensitive K\+ channels in follicle-enclosed Xenopus oocytes. Eur J Pharmacol 252(1): 117-121.
34. Seelinger M, Popescu R, Giessrigl B, Jarukamjorn K, Unger C, Wallnöfer B, Fritzer-Szekeres M, Szekeres T, Diaz R, Jäger W, Frisch R, Kopp B, Krupitza G (2012) Methanol extract of the ethnopharmaceutical remedy Smilax spinosa exhibits anti-neoplastic activity. Int J Oncol 41(3): 1164-1172.
35. Sheldon J, Taylor KW, Anderson J (1966) The effects of long-term acetohexamide treatment on pancreatic islet cell function in maturityonset diabetes. Metabolism 15(10): 874-883.
36. Spector AA, Gordon JA, Moore SA (1988) Hydroxyeicosatetraenoic acids (HETEs). Prog Lipid Res 27: 271-323.
37. Swanson TH, Green CL (1986) Nifedipine: more than a calcium channel blocker. Gen Pharmacol 17(3): 255-260.
38. Tan JL, Ravid S, Spudich JA (1992) Control of nonmuscle myosins by phosphorylation. Annu Rev Biochem 61: 721-759.
39. Tang DG, Timar J, Grossi IM, Renaud C, Kimler VA, Diglio CA, Taylor JD, Honn KV (1993) The lipoxygenase metabolite, 12(S)-HETE, induces a protein kinase C-dependent cytoskeletal rearrangement and retraction of microvascular endothelial cells. Exp Cell Res 207: 361-375.
40. Uchide K, Sakon M, Ariyoshi H, Nakamori S, Tokunaga M, Monden M (2007) Cancer cells cause vascular endothelial cell retraction via 12(S)-HETE secretion; the possible role of cancer cell derived microparticle. Ann Surg Oncol 14: 862-868.
41. Ueno S, Suzuki T, Susa N, Furukawa Y, Sugiyama M (1997) Effect of SKF-525A on liver metabolism and hepatotoxicity of tri-and dibutyltin compounds in mice. Arch Toxicol 71(8): 513-518.
42. van Zijl F, Krupitza G, Mikulits W (2011) Initial steps of metastasis: Cell invasion and endothelial transmigration. Rev Mutat Res 728(1-2): 23-34.
43. Viola K, Kopf S, Huttary N, Vonach C, Kretschy N, Teichmann M, Giessrigl B, Raab I, Stary S, Krieger S, Keller T, Bauer S, Hantusch B, Szekeres T, de Martin R, Jäger W, Mikulits W, Dolznig H, Krupitza G, Grusch M (2012) Bay11-7082 inhibits the disintegration of the lymphendothelial barrier triggered by MCF-7 breast cancer spheroids; the role of ICAM-1 and adhesion. Br J Cancer; e-pub ahead of print, 23 October 2012; doi: 10.1038/bjc.2012.485.
44. Vonach C, Viola K, Giessrigl B, Huttary N, Raab I, Kalt R, Krieger S, Vo NTP, Madlener S, Bauer S, Marian B, Hämmerle M, Kretschy N, Teichmann M, Hantusch B, Stary S, Unger C, Seelinger M, Eger A, Mader R, Jäger W, Schmidt W, Grusch M, Dolznig H, Mikulits W, Krupitza G (2011) NF-kB mediates the12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells. Br J Cancer 105(2): 263-271.
45. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF (2004) FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6(2): 154-161.
46. West KA, Zhang H, Brown MC, Nikolopoulos SN, Riedy MC, Horwitz AF, Turner CE (2001) The LD4 motif of paxillin regulates cell spreading and motility through an interaction with paxillin kinase linker (PKL). J Cell Biol 154(1): 161-176.
47. Wiemer G, Becker RH, Jablonka B, Rosenkranz G, Schölkens BA, Linz W (1992) Effects of converting enzyme inhibitors and the calcium antagonist nifedipine alone and in combination on precontracted isolated rabbit aortic rings. Arzneimittelforschung 42(6): 795-797.
48. Zeisberg M, Neilson EG (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119(6): 1429-1437.